Depression of oncogenecity by dephosphorylating and degrading BCR-ABLMiao Gao(Chongqing Medical University), Wenli Feng(Children's Hospital of Chongqing Medical University)OncotargetDecember 1, 201610.18632/oncotarget.13754Cited by 4SaveCiteExport RISWatch citationsRelated PapersInhibition of BCR/ABL Protein Expression by miR-203 Sensitizes for Imatinib Mesylate|PLoS ONE|2013|67Induction of apoptosis by directing oncogenic Bcr-Abl into the nucleus|Oncotarget|2013|16